Show simple item record

dc.contributor.advisorSveinbjørnsson, Baldur
dc.contributor.authorTümmler, Conny
dc.date.accessioned2020-01-12T22:05:19Z
dc.date.available2020-01-12T22:05:19Z
dc.date.issued2019-09-20
dc.description.abstract<p>The tumor microenvironment is a dynamic, constantly evolving interplay between tumor cells, immune cells, endothelial and other stromal cells, and the extracellular matrix. Inflammation is an essential part of the immune system’s response against malignant growth but also a powerful pro-tumorigenic factor as cancer cells can hijack inflammatory mediators to support tumor growth. Neuroblastoma is a malignancy of early childhood with 90% of cases being diagnosed by the age of five. Tumor-promoting functions of several inflammatory mediators have already been described in neuroblastoma. The aim of this thesis is to identify novel inflammatory mediators in neuroblastoma and extend the knowledge on neuroblastoma biology, a prerequisite for the development of novel therapeutic approaches and the improvement of existing therapies. <p>Chemerin is multifunctional chemoattractant protein and this work demonstrates a functional chemerin/CMKLR1 axis in neuroblastoma that supports pro-tumorigenic cell signaling pathways. Furthermore, inhibition of CMKLR1 impaired neuroblastoma clonogenicity <i>in vitro</i> and tumor growth <i>in vivo</i>. Spleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase with diverse functions in immunity but also inflammatory diseases and cancer. This work demonstrates the presence of SYK and phosphorylated SYK in neuroblastoma tissues and to a lesser extent neuroblastoma cell lines. SYK downregulation or inhibition reduced the cell viability of SYK-positive neuroblastoma cells. Furthermore, the SYK inhibitor BAY 61-3606 potentiated the effect of common chemotherapeutic drugs on neuroblastoma cells. The IL-17 family of cytokines and their receptors demonstrate versatile functions in host defense, immunity, inflammatory diseases, and cancer. This work describes the presence of the IL-17 receptors RA, RB, and RC in neuroblastoma cell lines and tissues. Recombinant IL-17 proteins modulate hepatocyte growth factor and Dickkopf-related protein 1 secretion, promote neuroblastoma cell migration but only modestly affect cell viability. Furthermore, the p19 subunit of the functionally related IL-23 was detected in neuroblastoma cell lines and tumor tissue.en_US
dc.description.doctoraltypeph.d.en_US
dc.description.popularabstractInflammation is an important part of the immune system’s defense mechanisms against injury, infection, and malignant cells. However, cancer cells can also take advantage of inflammatory signals and processes to support their growth and avoid destruction by the immune system. The focus of this work was to discover novel inflammatory mediators in neuroblastoma, a cancer of early childhood. The first study describes how the multifunctional protein chemerin, and its receptor CMKLR1, can support neuroblastoma growth. The second study demonstrates that inhibition of SYK, a protein involved in transmitting signals inside the cell, could support the efficacy of conventional anti-cancer drugs in neuroblastoma. Interleukins are molecules that mediate communication between cells and the third study examines the role of the interleukin 17 family in neuroblastoma. This thesis contributes to understanding the biology of neuroblastoma, a prerequisite to develop new therapeutic approaches.en_US
dc.description.sponsorshipUniversity of Tromsø-The Arctic University of Norway, Norwegian Childhood Cancer Society, Norwegian Childhood Cancer Society-Region Troms and Finnmark, Erna and Olav Aakre Foundation for Cancer Research, Norsk Biokjemisk Selskap, Swedish Childhood Cancer Foundation,en_US
dc.identifier.isbn978-82-7589-643-6
dc.identifier.urihttps://hdl.handle.net/10037/17068
dc.language.isoengen_US
dc.publisherUiT The Arctic University of Norwayen_US
dc.publisherUiT Norges arktiske universiteten_US
dc.relation.haspart<p>Paper I: Tümmler, C., Snapkov, I., Wickström, M., Moens, U., Ljungblad, L., Elfman, L.H.M., … Sveinbjørnsson, B. (2017). Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability <i>in vitro</i> and impairs tumor growth <i>in vivo</i>. <i>Oncotarget, 8</i>(56), 95135-95151. Also available in Munin at <a href=https://hdl.handle.net/10037/12937>https://hdl.handle.net/10037/12937</a>. <p>Paper II: Tümmler, C., Dumitriu, G., Wickström, M., Coopman, P., Valkov, A., Kogner, P., … Sveinbjørnsson, B. (2019). SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro. <i>Cancers, 11</i>(2), 202. Also available in Munin at <a href=https://hdl.handle.net/10037/15021>https://hdl.handle.net/10037/15021</a>. <p>Paper III: Tümmler, C., Marken, M., Valkov, A., Eissler, N., Kogner, P., Johnsen, J.I., … Sveinbjørnsson, B. The Interleukin 17 Family and Interleukin 23 in the Neuroblastoma Microenvironment. (Manuscript). Available in the file “thesis_entire.pdf”.en_US
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2019 The Author(s)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0en_US
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)en_US
dc.subject700en_US
dc.subjectChildhood canceren_US
dc.subject700en_US
dc.subjectInflammationen_US
dc.subject700en_US
dc.subjectNeuroblastomaen_US
dc.titleNovel Inflammatory Mediators in Neuroblastoma Tumorigenesisen_US
dc.typeDoctoral thesisen_US
dc.typeDoktorgradsavhandlingen_US


File(s) in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)